Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows
1. Omada Health to prescribe GLP-1s, enhancing its weight management program. 2. Membership exceeds 100,000, indicating strong growth potential. 3. Market for GLP-1s could reach $100 billion by 2030. 4. Omada will employ licensed providers for patient medication management. 5. Company reported quarterly earnings after its IPO in June.